PDS Biotechnology Corporation (PDSB) Reports $7.6M Q3 Net Loss

PDS Biotechnology Corporation reported a Q3 2026 net loss of $7.6M, or $0.11 per share, versus $9.0M, or $0.19 per share, in Q3 2025. Cash and cash equivalents were $15.2M at September 30, 2026.Material DetailsContext by AI AnalystThis is a quarterly financial update for a clinical-stage company pr…